Evidence map›Paper›PMID 39588550›Full record

ArticleFrontiers in psychiatry2024

Preliminary findings of a randomized controlled trial investigating the efficacy of transcranial magnetic stimulation in treatment-resistant depression: a

Julian Maciaszek, Joanna Rymaszewska, Tomasz Wieczorek, Patryk Piotrowski, Dorota Szcześniak, Jan A Beszłej, Monika Małecka, Bogna Bogudzińska, Adrianna Senczyszyn, Damian Siwicki and 5 more

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Julian Maciaszek *Department of Psychiatry, Wroclaw Medical University, Wrocław, Poland.
Joanna Rymaszewska *Department of Clinical Neuroscience, Faculty of Medicine, Wroclaw University of Science and Technology (WUST), Wrocław, Poland.
Tomasz WieczorekDepartment of Psychiatry, Wroclaw Medical University, Wrocław, Poland.
Patryk PiotrowskiDepartment of Psychiatry, Wroclaw Medical University, Wrocław, Poland.
Dorota SzcześniakDepartment of Psychiatry, Wroclaw Medical University, Wrocław, Poland.
Jan A BeszłejDepartment of Psychiatry, Wroclaw Medical University, Wrocław, Poland.
Monika MałeckaDepartment of Psychiatry, Wroclaw Medical University, Wrocław, Poland.
Bogna BogudzińskaDepartment of Psychiatry, Wroclaw Medical University, Wrocław, Poland.
Adrianna SenczyszynDepartment of Psychiatry, Wroclaw Medical University, Wrocław, Poland.
Damian SiwickiDepartment of Psychiatry, Wroclaw Medical University, Wrocław, Poland.
Marta BiercewiczDepartment of Psychiatry, Wroclaw Medical University, Wrocław, Poland.
Krzysztof KowalskiDepartment of Psychiatry, Wroclaw Medical University, Wrocław, Poland.
Anna ZimnyDepartment of Radiology, Wroclaw Medical University, Wroclaw, Poland.
Przemysław PodgórskiDepartment of Radiology, Wroclaw Medical University, Wroclaw, Poland.
Karolina Fila-PawłowskaDepartment of Clinical Neuroscience, Faculty of Medicine, Wroclaw University of Science and Technology (WUST), Wrocław, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Despite the high hopes for the use of transcranial magnetic stimulation (TMS) in the treatment of depression, between 30% and 60.5% of patients do not respond to stimulation. The factors contributing to non-response, especially those related to personality, remain insufficiently investigated. The main aim of our study was to compare the efficacy of active TMS and sham-placebo protocols in combined therapy of treatment-resistant depression with evaluation of possible personality disorders comorbidity. Methods: The study was conducted between December 2019 and December 2022, as a randomized, double-blind, active comparator-controlled and sham-controlled parallel trial. Patients (n = 41) were randomized into one of two experimental conditions (active TMS vs. placebo) and screened before and after stimulation as well as at a 3-month follow-up. Personality disorders were assessed with The Structured Clinical Interview for DSM-5 Personality Disorders. Results: There were no significant differences between the TMS active and sham groups in terms of general characteristics, coexisting personality disorders, and Montgomery-Åsberg Depression Rating Scale scores before stimulation, at the end of stimulation, and after 3 months of stimulation. However, linear regression analysis revealed significant negative associations between the coexistence of personality disorders and the reduction of depressive symptoms from baseline to the end of stimulation. The post-hoc exploratory analysis on the first phase of the RCT confirmed the presence of personality disorders to be a consistent negative influence on the reduction of depressive symptoms post-stimulation, regardless of protocol and experimental condition and demonstrated a smaller percentage reduction in depressive symptoms after stimulation in patients with personality disorders. Discussion: A central conclusion, based on our study, is that transcranial magnetic stimulation for treatment-resistant depression cannot be considered as a method independent of co-occurring personality disorders.

Indexed as

major depressive disorderpersonality disordersTBStheta burst stimulationTMStranscranial magnetic stimulationtreatment-resistant depression

Identifiers

PMID39588550
PMCPMC11586332

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.